Ameritas Advisory Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Sell |
7,187
-9,860
| -58% | -$379K | 0.01% | 649 |
|
|
2025
Q1 | $581K | Sell |
17,047
-17,908
| -51% | -$611K | 0.02% | 534 |
|
|
2024
Q4 | $1.18M | Buy |
34,955
+5,668
| +19% | +$192K | 0.04% | 370 |
|
|
2024
Q3 | $1.2M | Sell |
29,287
-7,908
| -21% | -$323K | 0.05% | 343 |
|
|
2024
Q2 | $1.43M | Sell |
37,195
-68
| -0.2% | -$2.62K | 0.05% | 322 |
|
|
2024
Q1 | $1.61M | Buy |
37,263
+9,488
| +34% | +$409K | 0.07% | 274 |
|
|
2023
Q4 | $1.06M | Sell |
27,775
-12,734
| -31% | -$484K | 0.06% | 274 |
|
|
2023
Q3 | $1.47M | Buy |
40,509
+23,690
| +141% | +$859K | 0.07% | 254 |
|
|
2023
Q2 | $569K | Sell |
16,819
-19,575
| -54% | -$662K | 0.07% | 264 |
|
|
2023
Q1 | $1.32M | Sell |
36,394
-12,053
| -25% | -$436K | 0.07% | 268 |
|
|
2022
Q4 | $1.7M | Buy |
+48,447
| New | +$1.7M | 0.08% | 245 |
|
|
2022
Q3 | – | Sell |
-11,961
| Closed | -$651K | – | 782 |
|
|
2022
Q2 | $651K | Sell |
11,961
-862
| -7% | -$46.9K | 0.04% | 391 |
|
|
2022
Q1 | $698K | Buy |
12,823
+778
| +6% | +$42.3K | 0.03% | 421 |
|
|
2021
Q4 | $664K | Buy |
+12,045
| New | +$664K | 0.02% | 429 |
|